[Gambling Disorder: epidemiology, diagnosis, interpretative models and intervention].
Gambling disorder is a frequently underdiagnosed and disabling disorder with a prevalence greatly increased in recent decades. For various reasons, only a small part of pathological gamblers seek a support making difficult an early identification and delaying the administration of appropriate treatment. In DSM-5, the disorder has been reclassified from an "Impulse-Control Disorder not elsewhere classified" to one of the "Substance-Related and Addictive Disorders" with the intention of improve the diagnosis, to better targeting the treatment and to stimulating further research efforts directed to the disorder. This article reviews assessment techniques, psychosocial and neurobiological factors in the development of pathological gambling and treatment strategies.
Centro Riferimento Alcologico Regione Lazio (CRARL), Dipartimento di Medicina Clinica, Sapienza Università di Roma - UOC delle Dipendenze e Patologie d'Abuso, ASL Rieti.
Giovanna
G
Coriale
Centro Riferimento Alcologico Regione Lazio (CRARL), Dipartimento di Medicina Clinica, Sapienza Università di Roma.
Mauro
M
Ceccanti
Casa di Cura Villa Von Siebenthal, Genzano di Roma - Dipartimento di Neuroscienze, Mental Health, and Sensory Organs (NESMOS), Scuola di Medicina e Psicologia, Sapienza Università di Roma.
Sergio
S
De Filippis
Dipartimento di Radiologia, Fondazione Santa Lucia, Roma.
Chiara
C
Falletta Caravasso
UOC delle Dipendenze e Patologie d'Abuso, ASL Rieti - Casa di Cura Villa Von Siebenthal, Genzano di Roma.
Simone
S
De Persis
D016739:Behavior, Addictive / Q000175:diagnosis* / Q000453:epidemiology* / Q000517:prevention & control; D015897:Comorbidity; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000175:diagnosis / Q000453:epidemiology; D005715:Gambling / Q000175:diagnosis* / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D011613:Psychotherapy / Q000379:methods; D011619:Psychotropic Drugs / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors
D011619:Psychotropic Drugs